Eric M Horwitz, MD
I joined Fox Chase's department of radiation oncology in 1997. In my practice, I specialize in treating patients with prostate cancer.
At Fox Chase, I have had the opportunity to develop advanced programs that include intensity modulated radiation therapy (IMRT), real-time intra-operative treatment planning for permanent prostate seed implants and temporary high-dose-rate (HDR) brachytherapy for prostate cancer. As a result, Fox Chase was the first in the Northeast United States to offer HDR implants to men with prostate cancer. As a radiation oncologist at Fox Chase, I have been privileged to be able to use these technologies to improve and expand the treatment of men with prostate cancer.
In addition, I have been involved in the first use of the BAT ultrasound for image guided radiation therapy (IGRT) and MRI treatment simulator for prostate cancer treatment planning both for permanent, low-dose prostate implants and external radiation therapy. Fox Chase was the first in the world to use the MRI simulator in radiation treatment planning.
Fox Chase was also one of the first hospitals to use Calypso® - brand new 4-dimensional monitoring technology, which allows us to more precisely and accurately guide radiation therapy. Miniature electromagnetic sensors (similar to seeds), called Beacon® transponders, are implanted into the prostate during treatment planning to continuously monitor position and motion of the organ in real-time. This technology helps us determine a tumor's location with great accuracy and continuously monitor its position throughout treatment.
Video
Introductory Video of Dr. Horwitz
Radiation Oncology Vice Chairman, Radiation Oncology
Meet other members of the genitourinary cancer treatment team.
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111-2497
To make an appointment, call:
215-728-3815.
For general information, call:
1-888-FOX CHASE.
An oncology certified nurse will assist you.
Clinical Expertise:
Prostate Cancer; Brachytherapy; Intensity-Modulated Radiation Therapy (IMRT)
Medical Education:
Albany Medical College, Albany, N.Y., 1992
Residency:
Radiation Oncology, William Beaumont Hospital, Royal Oak, Mich.
Certification:
American Board of Radiology, Radiation Oncology
Professional Societies:
American Brachytherapy Society;
American Society for Therapeutic Radiology and Oncology;
Radiation Therapy Oncology Group;
Eastern Cooperative Oncology Group
Scientific Report:
The Prostate Cancer Risk Assessment Program;
Radiation Oncology
(These links require Adobe® Acrobat Reader to view.)

Print this Page
E-mail This Page
